$27.77 -1.33 (%) Akorn Inc - NASDAQ

Jun. 24, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. John Paulson Bulks Up Health Care Bet

    GuruFocus | Feb. 17, 2016 | 17:02PM EST
  2. Top-Notch Funds Buying Constellation, Northrop Grumman

    IBD | Jan. 8, 2016 | 17:56PM EST
  3. Piper Jaffray: Akorn's Stock Will Be Delisted In 2016

    Benzinga | Dec. 18, 2015 | 11:18AM EST
  4. Piper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016

    Benzinga | Dec. 18, 2015 | 10:52AM EST
  5. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio

    Benzinga | Oct. 27, 2015 | 04:23AM EST
  6. Biotechs, Medicals Whacked As Nasdaq Trades Near Day's Low

    IBD | Oct. 6, 2015 | 13:23PM EST
  7. Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud's Phenomenon

    Benzinga | Sep. 17, 2015 | 07:00AM EST
  8. The Coming Drug-Patent Cliff Is Pushing This Portfolio Up

    Benzinga | Aug. 20, 2015 | 14:48PM EST
  9. Akorn's

    IBD | Aug. 4, 2015 | 18:41PM EST
  10. ETFs For The Next Pharma Takeover Candidates

    Benzinga | Jul. 28, 2015 | 13:08PM EST
  11. 5 Mid-Caps With Unsustainable Cash Burn Rates

    Benzinga | Jul. 27, 2015 | 09:23AM EST
  12. Pharma Pair Trade? Susquehanna Starts Lannet At Buy, Akorn At Neutral

    Benzinga | Jul. 21, 2015 | 11:31AM EST
  13. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest EPS Growth Forecast For Next 5 Years

    Benzinga | Jun. 19, 2015 | 04:43AM EST
  14. View, Use IBD's Key Stock Ratings In Light Of The Market

    IBD | Jun. 5, 2015 | 14:52PM EST
  15. Analyst Knocks High-Profile Biotech Merger Battle; Opportunities Elsewhere

    Benzinga | Jun. 3, 2015 | 17:05PM EST
  16. Health Care Mutual Funds Top In May: Close Look At Two Winners

    IBD | Jun. 2, 2015 | 18:43PM EST
  17. Who's The Next Big Pharma Acquisition?

    Benzinga | May. 29, 2015 | 11:20AM EST
  18. Celgene, Lannett Lead Boisterous Day For Drugmakers

    IBD | May. 18, 2015 | 15:56PM EST
  19. Analysts Disagree Over Significance of Akorn, Inc's Financial Errors

    GuruFocus | Apr. 28, 2015 | 17:17PM EST
  20. Nasdaq Leads Market Lower As Medical Stocks Tumble

    IBD | Apr. 27, 2015 | 16:16PM EST
  21. Stocks Fade; Apple Up Ahead Of Q2; Akorn Thrashed

    IBD | Apr. 27, 2015 | 11:46AM EST
  22. Akorn Downgraded, Stock Falls On 'Credibility Gap'

    IBD | Apr. 27, 2015 | 11:26AM EST
  23. Stocks Strong In Early Going; Autohome Breaks Out

    IBD | Apr. 27, 2015 | 10:43AM EST
  24. Morning Market Losers

    Benzinga | Apr. 27, 2015 | 09:53AM EST
  25. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 27, 2015 | 08:08AM EST
  26. After-Hours Movers Friday: Akorn Inc., Weight Watchers International Inc.

    Benzinga | Apr. 25, 2015 | 11:35AM EST
  27. Akron Will Restate Earnings; Drug Stock Tumbles

    IBD | Apr. 24, 2015 | 17:16PM EST
  28. Stocks Finish Solid Week; Akorn Restates 2014 Revenue

    IBD | Apr. 24, 2015 | 16:55PM EST
  29. Nasdaq Takes Lead In Mixed Open; Microsoft Surges, Biogen Dives

    IBD | Apr. 24, 2015 | 10:35AM EST
  30. Nasdaq Hits Record Close; Google, Amazon Rise After Hours

    IBD | Apr. 23, 2015 | 16:50PM EST
  31. Nasdaq Nears 2000 Bubble High As Volume Rises

    IBD | Apr. 23, 2015 | 14:58PM EST
  32. Akorn Leads Top Generic-Drug Stocks, Nears Buy Point

    IBD | Apr. 20, 2015 | 18:06PM EST
  33. 5 ETF Trends To Watch As Assets, Strategies Multiply

    IBD | Apr. 17, 2015 | 20:04PM EST
  34. 5 Top IBD 50 Stocks Stay On Course Despite Sell-Off

    IBD | Apr. 17, 2015 | 18:51PM EST
  35. IBD 50 Analysis: Akorn Evolves With Diverse Product Line

    IBD | Apr. 17, 2015 | 18:27PM EST
  36. Global Worries Sink U.S. Stocks; Apple Breaches Support Level

    IBD | Apr. 17, 2015 | 16:37PM EST
  37. Stock Futures Grapple Higher; Biogen, Akorn Lead IBD 50 List

    IBD | Apr. 15, 2015 | 09:04AM EST
  38. Alert: JP Morgan Just Started Akorn At Overweight

    Benzinga | Apr. 15, 2015 | 07:32AM EST
  39. Stock Market Takes A Break; Smith & Wesson Up After Close

    IBD | Mar. 3, 2015 | 16:59PM EST
  40. Stocks In Red Ahead Of Close; Alibaba At Post-IPO Low

    IBD | Mar. 3, 2015 | 15:14PM EST
  41. Stocks Off Lows In Afternoon; Akorn Dives 10%

    IBD | Mar. 3, 2015 | 13:23PM EST
  42. Monday's After-Hours Movers: Ocwen Financial, NutriSystem And McDermott International Lead The Pack

    Benzinga | Mar. 2, 2015 | 19:15PM EST
  43. AKORN PHARMA

    IBD | Mar. 2, 2015 | 18:45PM EST
  44. Akorn, Avago Lead IBD 50 Stocks In Earnings Growth

    IBD | Feb. 28, 2015 | 08:02AM EST
  45. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 27, 2015 | 16:27PM EST
  46. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 26, 2015 | 19:47PM EST
  47. Splunk Shoots Up After Hours; Monster Beverage Also Up

    IBD | Feb. 26, 2015 | 16:54PM EST
  48. 2 Top IBD 50 Stocks Are Surging Post-Earnings

    IBD | Feb. 26, 2015 | 15:11PM EST
  49. Stocks Mixed In Afternoon; Facebook Nears Buy Point

    IBD | Feb. 26, 2015 | 13:26PM EST
  50. IBD 50 Stock Akorn Hits New High On Q4 Beat

    IBD | Feb. 26, 2015 | 12:37PM EST
Trading Center